Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
18.34
-0.41 (-2.19%)
Dec 20, 2024, 4:00 PM EST - Market closed
Fulgent Genetics Market Cap
Fulgent Genetics has a market cap or net worth of $560.96 million as of December 20, 2024. Its market cap has decreased by -28.83% in one year.
Market Cap
560.96M
Enterprise Value
-244.39M
1-Year Change
-28.83%
Ranking
Category
Stock Price
$18.34
Market Cap Chart
Since September 29, 2016, Fulgent Genetics's market cap has increased from $156.50M to $560.96M, an increase of 258.44%. That is a compound annual growth rate of 16.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 561.00M | -34.52% |
| Dec 29, 2023 | 856.70M | -2.28% |
| Dec 30, 2022 | 876.70M | -70.78% |
| Dec 31, 2021 | 3.00B | 137.27% |
| Dec 31, 2020 | 1.26B | 423.90% |
| Dec 31, 2019 | 241.40M | 321.29% |
| Dec 31, 2018 | 57.30M | -26.63% |
| Dec 29, 2017 | 78.10M | -61.81% |
| Dec 30, 2016 | 204.50M | 30.67% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mineralys Therapeutics | 588.76M |
| Capricor Therapeutics | 586.56M |
| Altimmune | 581.80M |
| Simulations Plus | 579.54M |
| GRAIL | 575.92M |
| Surmodics | 571.75M |
| Annexon | 556.42M |
| SI-BONE | 547.29M |